L-Threonic Acid

L-Threonic Acid

SCHEMBL29669451

O=C(O)[C@H](O)[C@@H](O)CO.[Mg]

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 1/20 0.64
TSHR P16473 2/20 0.50
OR51E2 Q9H255 1/20 0.48
LMNA P02545 2/20 0.46
USP2 O75604 1/20 0.46
SLCO1B1 Q9Y6L6 1/20 0.46
CYP2C9 P11712 1/20 0.44
PGD P52209 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.40
TDP1 Q9NUW8 1/20 0.38
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
L-Threonic Acid SCHEMBL925622 0.97
L-Threonic Acid SCHEMBL120198 0.97
L-Threonic Acid SCHEMBL27279909 0.97 PDE4A (0.67) PDE4ATSHROR51E2LMNAUSP2
L-Threonic Acid SCHEMBL16609889 0.97
L-Threonic Acid SCHEMBL18614891 0.97
L-Threonic Acid SCHEMBL6437643 0.97
L-Threonic Acid SCHEMBL113115 0.97
L-Threonic Acid SCHEMBL29415344 0.94 PDE4A (0.64) PDE4ATSHROR51E2LMNAUSP2
L-Threonic Acid SCHEMBL8684453 0.94 PDE4A (0.64) PDE4ATSHROR51E2LMNAUSP2
L-Threonic Acid SCHEMBL29945675 0.94 PDE4A (0.64) PDE4ATSHROR51E2LMNAUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119661345-A Preparation method and application of L-magnesium threonate 苏州麦轮生物科技有限公司 2025-03-21 CN claimed
CN-119504413-A Synthesis method and application of magnesium L-threonate 浙江天启生化股份有限公司 2025-02-25 CN claimed
CN-115894216-B Preparation method of L-magnesium threonate 浦拉司科技(上海)有限责任公司 2024-08-06 CN claimed
CN-122004470-A Double-target-point nerve conduction supporting nutritional composition and preparation method thereof 河北雄安福赛生态科技有限公司 2026-05-12 CN disclosed
CN-120154711-A Application of magnesium nervonate composite preparation in protecting cerebral nervous system 深圳明杰生物工程有限公司 2025-06-17 CN disclosed
CN-119661345-A Preparation method and application of L-magnesium threonate 苏州麦轮生物科技有限公司 2025-03-21 CN disclosed
CN-119661345-A Preparation method and application of L-magnesium threonate 苏州麦轮生物科技有限公司 2025-03-21 CN disclosed
CN-119504413-A Synthesis method and application of magnesium L-threonate 浙江天启生化股份有限公司 2025-02-25 CN disclosed
CN-115894216-B Preparation method of L-magnesium threonate 浦拉司科技(上海)有限责任公司 2024-08-06 CN disclosed
CN-115067522-B Composition containing choline multiple vitamins and minerals, preparation method and application thereof 养生堂药业有限公司 2024-06-14 CN disclosed
CN-118076256-A Device and system for verifying and modifying device state transitions of aerosol-generating devices 莱战略控股公司 2024-05-24 CN disclosed
CN-117999010-A Method for verifying and modifying device state transitions of an aerosol-generating device 莱战略控股公司 2024-05-07 CN disclosed
CN-117815226-A Melatonin anhydrous swallow granule and preparation method thereof 天津市汉康医药生物技术有限公司 2024-04-05 CN disclosed
CN-117615663-A Aerosol precursor formulation 莱战略控股公司 2024-02-27 CN disclosed
CN-117442640-A Pharmaceutical composition for improving cardiovascular and cerebrovascular diseases and sleep quality and preventing senile dementia 安徽思诺达医药有限公司 2024-01-26 CN disclosed
CN-117004659-A Preparation method of L-magnesium threonate powder 郑州瑞普生物工程有限公司 2023-11-07 CN disclosed
CN-114732132-A Calcium-magnesium niacin liquid nutrient supplement for improving sleep and preparation method thereof 北京朗迪制药有限公司 2022-07-12 CN disclosed